MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1530/eje-21-1094

Медицинская библиотека · European journal of endocrinology · 2022

Revisiting growth hormone nadir cut-offs for remission in patients with acromegaly.

Kim Jiwon, Hwang Yoon-A, Park Yae Won, Moon Ju Hyung, Kim Eui Hyun, Hong Jae Won, Lee Eun Jig, Ku Cheol Ryong

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Over the past decade, the growth hormone (GH) nadir cut-off during the oral glucose tolerance test for remission in patients with acromegaly was changed from 0.4 to 1.0 μg/L due to the limited use of ultrasensitive detection kits to measure GH levels. However, the optimal cut-off level for GH nadir remains unclear. This retrospective study aimed to investigate the association between different GH nadir cut-offs and prognosis in patients with acromegaly.

DESIGN AND

METHODS

A total of 285 patients with acromegaly with a glucose-suppressed GH nadir <1 μg/L at 3-6 months after trans-sphenoidal adenomectomy were divided into two groups according to the glucose-suppressed GH nadir levels at 3-6 months post-operatively (group A: <0.4 μg/L; group B: 0.4-1.0 μg/L). GH levels were measured using an ultrasensitive IRMA. The clinical, hormonal, metabolic, and neuroradiological data of the two groups were compared.

RESULTS

Female sex, as well as confirmed macroadenomas, was significantly overrepresented in group B. The 5-year rate of patients who achieved nadir GH < 1.0 μg/L and age- and sex-matched normal IGF-1 was significantly higher in group A than that in group B. However, there was no significant difference between the two groups in metabolic parameters at 12 months post-operatively.

CONCLUSION

Different GH nadir cut-offs were associated with different 5-year rates of patients who achieved nadir GH <1.0 μg/L and age- and sex-matched normal IGF-1, suggesting that a strict GH nadir threshold of 0.4 μg/L correlates better with remission.

Для цитирования: Kim Jiwon, Hwang Yoon-A, Park Yae Won, Moon Ju Hyung, Kim Eui Hyun, Hong Jae Won, Lee Eun Jig, Ku Cheol Ryong. Revisiting growth hormone nadir cut-offs for remission in patients with acromegaly.. European journal of endocrinology. 2022. DOI: 10.1530/eje-21-1094.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.